Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk.
@rwth.bsky.social
@brunslab.bsky.social
@easlnews.bsky.social
#Cirrhosis #ACLF #EASL2025"
@rwth.bsky.social
@brunslab.bsky.social
@easlnews.bsky.social
#Cirrhosis #ACLF #EASL2025"
May 10, 2025 at 8:58 AM
Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk.
@rwth.bsky.social
@brunslab.bsky.social
@easlnews.bsky.social
#Cirrhosis #ACLF #EASL2025"
@rwth.bsky.social
@brunslab.bsky.social
@easlnews.bsky.social
#Cirrhosis #ACLF #EASL2025"
The Global ACLF Consensus: the ‘Istanbul Document’
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
September 26, 2026 at 1:15 PM
The Global ACLF Consensus: the ‘Istanbul Document’
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
CCR Journal Watch
https://criticalcarereviews.com/latest-evidence/journal-watch
Kenoh demonstrates the lariat for a martial artist who wants to adapt a pro-wrestling move for use in martial arts! 🤼
www.youtube.com/watch?v=AClf...
www.youtube.com/watch?v=AClf...
September 9, 2026 at 8:13 PM
Kenoh demonstrates the lariat for a martial artist who wants to adapt a pro-wrestling move for use in martial arts! 🤼
www.youtube.com/watch?v=AClf...
www.youtube.com/watch?v=AClf...
Next at the DECISION Networking Session at #EASL2025, Theresa Wirtz (UKA) presents scRNA-seq data showing a monocyte subset linked to ACLF risk.
Fascinating translational science in action!
@brunslab.bsky.social ky.social @easlnews.bsky.social ky.social
#scRNAseq #ACLF
Fascinating translational science in action!
@brunslab.bsky.social ky.social @easlnews.bsky.social ky.social
#scRNAseq #ACLF
May 9, 2025 at 8:09 AM
Next at the DECISION Networking Session at #EASL2025, Theresa Wirtz (UKA) presents scRNA-seq data showing a monocyte subset linked to ACLF risk.
Fascinating translational science in action!
@brunslab.bsky.social ky.social @easlnews.bsky.social ky.social
#scRNAseq #ACLF
Fascinating translational science in action!
@brunslab.bsky.social ky.social @easlnews.bsky.social ky.social
#scRNAseq #ACLF
Excellent, practical talk by @jasmohanbajaj.bsky.social on ACLF, how to diagnose early and how to manage organ failures
#AHNGI&Liver
#Liversky
#AHNGI&Liver
#Liversky
April 5, 2025 at 12:45 PM
Excellent, practical talk by @jasmohanbajaj.bsky.social on ACLF, how to diagnose early and how to manage organ failures
#AHNGI&Liver
#Liversky
#AHNGI&Liver
#Liversky
💊 Non-selective #betablocker use was associated with improved survival across all stages of chronic #LiverDisease, including pre-ACLF & #ACLF:
👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al.
#EASL2026 #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al.
#EASL2026 #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
May 30, 2026 at 2:57 PM
💊 Non-selective #betablocker use was associated with improved survival across all stages of chronic #LiverDisease, including pre-ACLF & #ACLF:
👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al.
#EASL2026 #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
👏 #POSTER SAT-458-YI by Josune Cabello Calleja et al.
#EASL2026 #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
November 13, 2024 at 3:45 AM
🌍 Which #ACLF score performs best?
In 3,370 COSSH cohort patients, the A-TANGO score matched the COSSH-ACLF Score for ACLF diagnosis + short-term #mortality prediction, while other models markedly underestimated ACLF.
👉 Visit Meiqian Hu's poster tomorrow!
🔍 #Poster SAT-476
@rajivjalan.bsky.social
In 3,370 COSSH cohort patients, the A-TANGO score matched the COSSH-ACLF Score for ACLF diagnosis + short-term #mortality prediction, while other models markedly underestimated ACLF.
👉 Visit Meiqian Hu's poster tomorrow!
🔍 #Poster SAT-476
@rajivjalan.bsky.social
May 29, 2026 at 5:54 PM
🌍 Which #ACLF score performs best?
In 3,370 COSSH cohort patients, the A-TANGO score matched the COSSH-ACLF Score for ACLF diagnosis + short-term #mortality prediction, while other models markedly underestimated ACLF.
👉 Visit Meiqian Hu's poster tomorrow!
🔍 #Poster SAT-476
@rajivjalan.bsky.social
In 3,370 COSSH cohort patients, the A-TANGO score matched the COSSH-ACLF Score for ACLF diagnosis + short-term #mortality prediction, while other models markedly underestimated ACLF.
👉 Visit Meiqian Hu's poster tomorrow!
🔍 #Poster SAT-476
@rajivjalan.bsky.social
🧬 Impaired endothelial FoxO1 signalling may contribute to endothelial dysfunction in ACLF.
👉 #POSTER FRI-428-YI by Fabian Schachteli et al.
#EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
👉 #POSTER FRI-428-YI by Fabian Schachteli et al.
#EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
May 29, 2026 at 11:03 AM
🧬 Impaired endothelial FoxO1 signalling may contribute to endothelial dysfunction in ACLF.
👉 #POSTER FRI-428-YI by Fabian Schachteli et al.
#EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
👉 #POSTER FRI-428-YI by Fabian Schachteli et al.
#EASL2026 #EASLCongress #ACLF #Cirrhosis #Hepatology
@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social
🧬 Maladaptive emergency #myelopoiesis may drive progression from acutely decompensated cirrhosis to ACLF.
👉 #POSTER FRI-388-YI by Zhujun Cao et al.
#EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology
#DecompensatedCirrhosis
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
👉 #POSTER FRI-388-YI by Zhujun Cao et al.
#EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology
#DecompensatedCirrhosis
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
May 29, 2026 at 10:54 AM
🧬 Maladaptive emergency #myelopoiesis may drive progression from acutely decompensated cirrhosis to ACLF.
👉 #POSTER FRI-388-YI by Zhujun Cao et al.
#EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology
#DecompensatedCirrhosis
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
👉 #POSTER FRI-388-YI by Zhujun Cao et al.
#EASLCongress #EASL2026 #ACLF #Cirrhosis #Immunology
#DecompensatedCirrhosis
@medblab.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
🧬Poster THU-159-YI
Can dimethylarginines (DAS) predict #ACLF before it strikes?
At #EASL2025, Kohilan Gananandan (@ucl.ac.uk) presents new data validating DAS as a biomarker for pre-ACLF and outcome prediction post-acute #decompensation in two large EU cohorts.
#Biomarkers #Cirrhosis #LiverResearch
Can dimethylarginines (DAS) predict #ACLF before it strikes?
At #EASL2025, Kohilan Gananandan (@ucl.ac.uk) presents new data validating DAS as a biomarker for pre-ACLF and outcome prediction post-acute #decompensation in two large EU cohorts.
#Biomarkers #Cirrhosis #LiverResearch
May 8, 2025 at 12:44 PM
🧬Poster THU-159-YI
Can dimethylarginines (DAS) predict #ACLF before it strikes?
At #EASL2025, Kohilan Gananandan (@ucl.ac.uk) presents new data validating DAS as a biomarker for pre-ACLF and outcome prediction post-acute #decompensation in two large EU cohorts.
#Biomarkers #Cirrhosis #LiverResearch
Can dimethylarginines (DAS) predict #ACLF before it strikes?
At #EASL2025, Kohilan Gananandan (@ucl.ac.uk) presents new data validating DAS as a biomarker for pre-ACLF and outcome prediction post-acute #decompensation in two large EU cohorts.
#Biomarkers #Cirrhosis #LiverResearch
February 18, 2025 at 12:51 PM
Feel free to follow the new A-TANGO Consortium + #hepatology Starter Pack go.bsky.app/Tc8YSWq
#LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals
@rajivjalan.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@jhepatology.bsky.social
@ebtapper.bsky.social
#LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals
@rajivjalan.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@jhepatology.bsky.social
@ebtapper.bsky.social
April 25, 2025 at 9:38 PM
Feel free to follow the new A-TANGO Consortium + #hepatology Starter Pack go.bsky.app/Tc8YSWq
#LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals
@rajivjalan.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@jhepatology.bsky.social
@ebtapper.bsky.social
#LiverSky #LiverResearch #LiverDisease #hepatitis #cirrhosis #ACLF #HepatologyJournals
@rajivjalan.bsky.social
@europeliver.bsky.social
@easlnews.bsky.social
@jhepatology.bsky.social
@ebtapper.bsky.social
Back home from an inspiring & energising #EASLCongress in sunny + hot Barcelona 🌅.
These were my personal highlights (sound on 🔊) - what were your‘s? 😎
#Barcelona #EASL2026
#LiverDisease #LiverHealth
#ACLF
@europeliver.bsky.social
@medblab.bsky.social
@horizoneu.bsky.social
@easlnews.bsky.social
These were my personal highlights (sound on 🔊) - what were your‘s? 😎
#Barcelona #EASL2026
#LiverDisease #LiverHealth
#ACLF
@europeliver.bsky.social
@medblab.bsky.social
@horizoneu.bsky.social
@easlnews.bsky.social
June 1, 2026 at 3:13 PM
Back home from an inspiring & energising #EASLCongress in sunny + hot Barcelona 🌅.
These were my personal highlights (sound on 🔊) - what were your‘s? 😎
#Barcelona #EASL2026
#LiverDisease #LiverHealth
#ACLF
@europeliver.bsky.social
@medblab.bsky.social
@horizoneu.bsky.social
@easlnews.bsky.social
These were my personal highlights (sound on 🔊) - what were your‘s? 😎
#Barcelona #EASL2026
#LiverDisease #LiverHealth
#ACLF
@europeliver.bsky.social
@medblab.bsky.social
@horizoneu.bsky.social
@easlnews.bsky.social
📣 Today: #POSTER TOP-203, congrats 🥳
A rising international star is A-TANGO #YoungInvestigator Wenting Tan, UCL
👉 Recombinant insulin-like growth factor-1 #IGF1: a novel therapy for #patients with #cirrhosis + #ACLF
👉 Topic: Cirrhosis & Complications
#LiverFailure #ACLF
@rajivjalan.bsky.social
A rising international star is A-TANGO #YoungInvestigator Wenting Tan, UCL
👉 Recombinant insulin-like growth factor-1 #IGF1: a novel therapy for #patients with #cirrhosis + #ACLF
👉 Topic: Cirrhosis & Complications
#LiverFailure #ACLF
@rajivjalan.bsky.social
May 8, 2025 at 11:17 AM
📣 Today: #POSTER TOP-203, congrats 🥳
A rising international star is A-TANGO #YoungInvestigator Wenting Tan, UCL
👉 Recombinant insulin-like growth factor-1 #IGF1: a novel therapy for #patients with #cirrhosis + #ACLF
👉 Topic: Cirrhosis & Complications
#LiverFailure #ACLF
@rajivjalan.bsky.social
A rising international star is A-TANGO #YoungInvestigator Wenting Tan, UCL
👉 Recombinant insulin-like growth factor-1 #IGF1: a novel therapy for #patients with #cirrhosis + #ACLF
👉 Topic: Cirrhosis & Complications
#LiverFailure #ACLF
@rajivjalan.bsky.social
🎥 Can we predict liver failure before it happens?
Researchers at the University of Copenhagen are identifying biomarkers (e.g. metabolites) in a variety of samples to detect ACLF risk early - enabling potentially life-saving interventions.
#LiverFailure #ACLF #PrecisionMedicine
youtu.be/1s6Rp2If_-o
Researchers at the University of Copenhagen are identifying biomarkers (e.g. metabolites) in a variety of samples to detect ACLF risk early - enabling potentially life-saving interventions.
#LiverFailure #ACLF #PrecisionMedicine
youtu.be/1s6Rp2If_-o
MICROB-PREDICT - Camila Alvarez-Silva (University of Copenhagen) on metabolite biomarkers of ACLF
YouTube video by concentris research management
youtu.be
March 30, 2026 at 11:49 AM
🎥 Can we predict liver failure before it happens?
Researchers at the University of Copenhagen are identifying biomarkers (e.g. metabolites) in a variety of samples to detect ACLF risk early - enabling potentially life-saving interventions.
#LiverFailure #ACLF #PrecisionMedicine
youtu.be/1s6Rp2If_-o
Researchers at the University of Copenhagen are identifying biomarkers (e.g. metabolites) in a variety of samples to detect ACLF risk early - enabling potentially life-saving interventions.
#LiverFailure #ACLF #PrecisionMedicine
youtu.be/1s6Rp2If_-o
Last chance to register: docs.google.com/forms/d/e/1F...
Don't miss out 😊. It also includes an
👉 Expert Panel: What have we learned about acute-on-chronic #LiverFailure #ACLF at #EASLCongress 2025
@easlnews.bsky.social
@europeliver.bsky.social
@decision4liver.bsky.social
#LiverSky
#cirrhosis
Don't miss out 😊. It also includes an
👉 Expert Panel: What have we learned about acute-on-chronic #LiverFailure #ACLF at #EASLCongress 2025
@easlnews.bsky.social
@europeliver.bsky.social
@decision4liver.bsky.social
#LiverSky
#cirrhosis
May 5, 2025 at 8:57 PM
Last chance to register: docs.google.com/forms/d/e/1F...
Don't miss out 😊. It also includes an
👉 Expert Panel: What have we learned about acute-on-chronic #LiverFailure #ACLF at #EASLCongress 2025
@easlnews.bsky.social
@europeliver.bsky.social
@decision4liver.bsky.social
#LiverSky
#cirrhosis
Don't miss out 😊. It also includes an
👉 Expert Panel: What have we learned about acute-on-chronic #LiverFailure #ACLF at #EASLCongress 2025
@easlnews.bsky.social
@europeliver.bsky.social
@decision4liver.bsky.social
#LiverSky
#cirrhosis
🤩 Great attendance & active discussion at #EASLCongress today! Very insightful & interactive Networking Session on the evolving definition and #RiskStratification of ACLF, highlighting the new #ATANGOscore & the urgent need for international #Harmonisation of #ACLF criteria.
@rajivjalan.bsky.social
@rajivjalan.bsky.social
May 29, 2026 at 9:51 AM
🤩 Great attendance & active discussion at #EASLCongress today! Very insightful & interactive Networking Session on the evolving definition and #RiskStratification of ACLF, highlighting the new #ATANGOscore & the urgent need for international #Harmonisation of #ACLF criteria.
@rajivjalan.bsky.social
@rajivjalan.bsky.social
updated the IBCC section on alcoholic hepatitis.
AGA 2024 guidelines seem sensible & useful (picture below)
Key points:
🍺Steroid recommended for MELD>20
🍺Aggressive multiorgan support PRN (may have hepatorenal syndrome, sepsis, etc)
🍺Consider acetylcysteine
emcrit.org/ibcc/aclf/#a... #EMIMCC
AGA 2024 guidelines seem sensible & useful (picture below)
Key points:
🍺Steroid recommended for MELD>20
🍺Aggressive multiorgan support PRN (may have hepatorenal syndrome, sepsis, etc)
🍺Consider acetylcysteine
emcrit.org/ibcc/aclf/#a... #EMIMCC
October 30, 2025 at 7:56 PM
updated the IBCC section on alcoholic hepatitis.
AGA 2024 guidelines seem sensible & useful (picture below)
Key points:
🍺Steroid recommended for MELD>20
🍺Aggressive multiorgan support PRN (may have hepatorenal syndrome, sepsis, etc)
🍺Consider acetylcysteine
emcrit.org/ibcc/aclf/#a... #EMIMCC
AGA 2024 guidelines seem sensible & useful (picture below)
Key points:
🍺Steroid recommended for MELD>20
🍺Aggressive multiorgan support PRN (may have hepatorenal syndrome, sepsis, etc)
🍺Consider acetylcysteine
emcrit.org/ibcc/aclf/#a... #EMIMCC
NHS to trial potentially life-saving treatment for deadly liver disease
NHS to trial potentially life-saving treatment for deadly liver disease
Acute-on-chronic liver failure will be treated with device that cleans patients’ blood corrupted by toxins
The NHS is to trial a potentially life-saving new treatment for a deadly liver disease that causes the body’s vital organs to fail.
Thirteen major hospitals will use a device that cleans patients’ blood that has become corrupted by toxins as a result of them developing acute-on-chronic liver failure (ACLF). Continue reading...
www.theguardian.com
December 21, 2025 at 7:16 AM
NHS to trial potentially life-saving treatment for deadly liver disease
🚨Take this 15 min survey to shape the future of #Hepatology:
👉 survey.alchemer.eu/s3/91085482/...
🦠 #Microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #Cirrhosis / #ACLF
⏳Survey closes on 17 May
@easlnews.bsky.social
👉 survey.alchemer.eu/s3/91085482/...
🦠 #Microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #Cirrhosis / #ACLF
⏳Survey closes on 17 May
@easlnews.bsky.social
April 16, 2026 at 12:34 PM
🚨Take this 15 min survey to shape the future of #Hepatology:
👉 survey.alchemer.eu/s3/91085482/...
🦠 #Microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #Cirrhosis / #ACLF
⏳Survey closes on 17 May
@easlnews.bsky.social
👉 survey.alchemer.eu/s3/91085482/...
🦠 #Microbiome-based mechanisms & biomarkers for improved patient stratification + prediction of therapeutic response in decompensated #Cirrhosis / #ACLF
⏳Survey closes on 17 May
@easlnews.bsky.social
Have a glimpse at Wednesday's A-TANGO highlights at #EASLCongress in Amsterdam! 🤩
#ACLF #cirrhosis #PatientAdvocacy #PatientEvent #hepatology #GTAK #CombinatorialTherapy #MASLD #HealthcareDisparities
@europeliver.bsky.social
@easlnews.bsky.social
@rajivjalan.bsky.social
@korenjak.bsky.social
#ACLF #cirrhosis #PatientAdvocacy #PatientEvent #hepatology #GTAK #CombinatorialTherapy #MASLD #HealthcareDisparities
@europeliver.bsky.social
@easlnews.bsky.social
@rajivjalan.bsky.social
@korenjak.bsky.social
May 6, 2025 at 8:37 PM
Have a glimpse at Wednesday's A-TANGO highlights at #EASLCongress in Amsterdam! 🤩
#ACLF #cirrhosis #PatientAdvocacy #PatientEvent #hepatology #GTAK #CombinatorialTherapy #MASLD #HealthcareDisparities
@europeliver.bsky.social
@easlnews.bsky.social
@rajivjalan.bsky.social
@korenjak.bsky.social
#ACLF #cirrhosis #PatientAdvocacy #PatientEvent #hepatology #GTAK #CombinatorialTherapy #MASLD #HealthcareDisparities
@europeliver.bsky.social
@easlnews.bsky.social
@rajivjalan.bsky.social
@korenjak.bsky.social
🎥 LIVE from the #EASLStudio at #EASL2025!
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
May 9, 2025 at 10:59 AM
🎥 LIVE from the #EASLStudio at #EASL2025!
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.
@debbieshawcross.bsky.social (KCL) leads today’s deep dive into “Moving towards recompensation: Putting out the fire that fuels decompensation and ACLF” - tackling the key drivers of decompensation and ACLF, from systemic inflammation to portal hypertension.